Archives of Pediatric Infectious Diseases

Published by: Kowsar

Virologic Evidences of Active Herpesviridae Infection in Children With Guillain-Barre Syndrome

Shahnaz Armin 1 , * , Farhad Mahvelati Shamsabadi 1 , Azadeh Kiomarci 1 and Farzane Jadali 1
Authors Information
1 Pediatric Infections Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Pediatric Infectious Diseases: January 01, 2014, 2 (1); 169-173
  • Published Online: January 7, 2014
  • Article Type: Research Article
  • Received: March 21, 2013
  • Revised: May 27, 2013
  • Accepted: July 4, 2013
  • DOI: 10.5812/pedinfect.11251

To Cite: Armin S, Mahvelati Shamsabadi F, Kiomarci A, Jadali F. Virologic Evidences of Active Herpesviridae Infection in Children With Guillain-Barre Syndrome, Arch Pediatr Infect Dis. 2014 ; 2(1):169-173. doi: 10.5812/pedinfect.11251.

Copyright © 2014, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet. 2005; 366(9497): 1653-66[DOI][PubMed]
  • 2. Pritchard J, Hughes RA. Guillain-Barre syndrome. Lancet. 2004; 363(9427): 2186-8[DOI][PubMed]
  • 3. McCarthy N, Giesecke J. Incidence of Guillain-Barre syndrome following infection with Campylobacter jejuni. Am J Epidemiol. 2001; 153(6): 610-4[PubMed]
  • 4. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med. 2000; 342(9): 635-45[DOI][PubMed]
  • 5. Ho M. The history of cytomegalovirus and its diseases. Med Microbiol Immunol. 2008; 197(2): 65-73[DOI][PubMed]
  • 6. Kuijf ML, Ang CW, van Doorn PA, Niesters HG, Jacobs BC. Presence or absence of cytomegalovirus in cerebrospinal fluid from patients with Guillain-Barre syndrome? J Infect Dis. 2006; 193(10): 1471-2[DOI][PubMed]
  • 7. Weinberg A, Bloch KC, Li S, Tang YW, Palmer M, Tyler KL. Dual infections of the central nervous system with Epstein-Barr virus. J Infect Dis. 2005; 191(2): 234-7[DOI][PubMed]
  • 8. Choe YJ, Cho H, Bae GR, Lee JK. Guillain-Barre syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition. Vaccine. 2011; 29(11): 2066-70[DOI][PubMed]
  • 9. Marin LF, Abrahao A, Carvalho FA, Santos WA, Dallalba CC, Barcelos LB, et al. Guillain-Barre syndrome associated with H1N1 vaccination. Arq Neuropsiquiatr. 2010; 68(6): 974-5[PubMed]
  • 10. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain. 2002; 125: 2591-625[PubMed]
  • 11. Satyanand Tyagi R, Yadav P, Saxena S. Management of Guillain Barre Syndrome- An Autoimmune Disorder: A Review. IJABPT. 2010; 1(2): 722-728
  • 12. Rabinstein AA. Guillain-Barré Syndrome. Open General Intern Med J. 2007; 1: 13-22
  • 13. Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry. 2001; 70(1): 50-5[PubMed]
  • 14. Kuwabara S. Guillain-barre syndrome. Curr Neurol Neurosci Rep. 2007; 7(1): 57-62[PubMed]
  • 15. Link H, Wahren B, Norrby E. Pleocytosis and immunoglobulin changes in cerebrospinal fluid and herpesvirus serology in patients with Guillain-Barre syndrome. J Clin Microbiol. 1979; 9(3): 305-16[PubMed]
  • 16. Figueiredo CA, Klautau GB, Afonso AM, Castrignano SB, Oliveira MI, Curti SP, et al. Isolation and genotype analysis of rubella virus from a case of Guillain-Barre syndrome. J Clin Virol. 2008; 43(3): 343-5[DOI][PubMed]
  • 17. Orlikowski D, Porcher R, Sivadon-Tardy V, Quincampoix JC, Raphael JC, Durand MC, et al. Guillain-Barre syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis. 2011; 52(7): 837-44[DOI][PubMed]
  • 18. Steininger C, Popow-Kraupp T, Seiser A, Gueler N, Stanek G, Puchhammer E. Presence of cytomegalovirus in cerebrospinal fluid of patients with Guillain-Barre syndrome. J Infect Dis. 2004; 189(6): 984-9[DOI][PubMed]
  • 19. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol. 1990; 27 Suppl-4[PubMed]
  • 20. Volpi A. Epstein-Barr virus and human herpesvirus type 8 infections of the central nervous system. Herpes. 2004; 11 Suppl 2: 120A-127A[PubMed]
  • 21. Winer JB, Hughes RA, Anderson MJ, Jones DM, Kangro H, Watkins RP. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry. 1988; 51(5): 613-8[PubMed]
  • 22. Asai Y, Fujita R, Nakayasu H, Suzuki K, Kaneto T, Nakashima K. Urinary Retention as an Initial Symptom of Acute Meningo-Encephalo-Radiculitis in Epstein-Barr Virus Infection. Yonago Acta medica. 2008; 51: 83–8
  • 23. Bernsen HJ, Van Loon AM, Poels RF, Verhagen WI, Frenken CW. Herpes simplex virus specific antibody determined by immunoblotting in cerebrospinal fluid of a patient with the Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 1989; 52(6): 788-91[PubMed]
  • 24. Gerken G, Trautmann F, Kohler H, Falke D, Bohl J, Nix W, et al. Rare association of herpes simplex virus IgM-specific antibodies and Guillain-Barre syndrome successfully treated with plasma exchange and immunosuppression. Klin Wochenschr. 1985; 63(10): 468-74[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments